_version_ 1784882657595752448
author Marinos, Alejandro
Ramdial, Jeremy L
Saliba, Rima M.
Khawaja, Fareed
Alousi, Amin M.
Rondon, Gabriela
Chen, Julianne
Ledesma, Celina
Chemaly, Dr. Roy F.
Champlin, Richard E.
Marin, David
Daher, May
Rezvani, Katayoun
Shpall, Elizabeth J.
author_facet Marinos, Alejandro
Ramdial, Jeremy L
Saliba, Rima M.
Khawaja, Fareed
Alousi, Amin M.
Rondon, Gabriela
Chen, Julianne
Ledesma, Celina
Chemaly, Dr. Roy F.
Champlin, Richard E.
Marin, David
Daher, May
Rezvani, Katayoun
Shpall, Elizabeth J.
author_sort Marinos, Alejandro
collection PubMed
description
format Online
Article
Text
id pubmed-9899537
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-98995372023-02-06 Long-Term Follow-up Outcomes of Patients That Underwent Allogeneic or Autologous Hematopoietic Transplant Shortly after a COVID-19 Infection Marinos, Alejandro Ramdial, Jeremy L Saliba, Rima M. Khawaja, Fareed Alousi, Amin M. Rondon, Gabriela Chen, Julianne Ledesma, Celina Chemaly, Dr. Roy F. Champlin, Richard E. Marin, David Daher, May Rezvani, Katayoun Shpall, Elizabeth J. Transplant Cell Ther Poster Session: Infectious Diseases and Cytotoxic T Lymphocytes American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. 2023-02 2023-02-06 /pmc/articles/PMC9899537/ http://dx.doi.org/10.1016/S2666-6367(23)00518-3 Text en Copyright © 2023 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Poster Session: Infectious Diseases and Cytotoxic T Lymphocytes
Marinos, Alejandro
Ramdial, Jeremy L
Saliba, Rima M.
Khawaja, Fareed
Alousi, Amin M.
Rondon, Gabriela
Chen, Julianne
Ledesma, Celina
Chemaly, Dr. Roy F.
Champlin, Richard E.
Marin, David
Daher, May
Rezvani, Katayoun
Shpall, Elizabeth J.
Long-Term Follow-up Outcomes of Patients That Underwent Allogeneic or Autologous Hematopoietic Transplant Shortly after a COVID-19 Infection
title Long-Term Follow-up Outcomes of Patients That Underwent Allogeneic or Autologous Hematopoietic Transplant Shortly after a COVID-19 Infection
title_full Long-Term Follow-up Outcomes of Patients That Underwent Allogeneic or Autologous Hematopoietic Transplant Shortly after a COVID-19 Infection
title_fullStr Long-Term Follow-up Outcomes of Patients That Underwent Allogeneic or Autologous Hematopoietic Transplant Shortly after a COVID-19 Infection
title_full_unstemmed Long-Term Follow-up Outcomes of Patients That Underwent Allogeneic or Autologous Hematopoietic Transplant Shortly after a COVID-19 Infection
title_short Long-Term Follow-up Outcomes of Patients That Underwent Allogeneic or Autologous Hematopoietic Transplant Shortly after a COVID-19 Infection
title_sort long-term follow-up outcomes of patients that underwent allogeneic or autologous hematopoietic transplant shortly after a covid-19 infection
topic Poster Session: Infectious Diseases and Cytotoxic T Lymphocytes
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899537/
http://dx.doi.org/10.1016/S2666-6367(23)00518-3
work_keys_str_mv AT marinosalejandro longtermfollowupoutcomesofpatientsthatunderwentallogeneicorautologoushematopoietictransplantshortlyafteracovid19infection
AT ramdialjeremyl longtermfollowupoutcomesofpatientsthatunderwentallogeneicorautologoushematopoietictransplantshortlyafteracovid19infection
AT salibarimam longtermfollowupoutcomesofpatientsthatunderwentallogeneicorautologoushematopoietictransplantshortlyafteracovid19infection
AT khawajafareed longtermfollowupoutcomesofpatientsthatunderwentallogeneicorautologoushematopoietictransplantshortlyafteracovid19infection
AT alousiaminm longtermfollowupoutcomesofpatientsthatunderwentallogeneicorautologoushematopoietictransplantshortlyafteracovid19infection
AT rondongabriela longtermfollowupoutcomesofpatientsthatunderwentallogeneicorautologoushematopoietictransplantshortlyafteracovid19infection
AT chenjulianne longtermfollowupoutcomesofpatientsthatunderwentallogeneicorautologoushematopoietictransplantshortlyafteracovid19infection
AT ledesmacelina longtermfollowupoutcomesofpatientsthatunderwentallogeneicorautologoushematopoietictransplantshortlyafteracovid19infection
AT chemalydrroyf longtermfollowupoutcomesofpatientsthatunderwentallogeneicorautologoushematopoietictransplantshortlyafteracovid19infection
AT champlinricharde longtermfollowupoutcomesofpatientsthatunderwentallogeneicorautologoushematopoietictransplantshortlyafteracovid19infection
AT marindavid longtermfollowupoutcomesofpatientsthatunderwentallogeneicorautologoushematopoietictransplantshortlyafteracovid19infection
AT dahermay longtermfollowupoutcomesofpatientsthatunderwentallogeneicorautologoushematopoietictransplantshortlyafteracovid19infection
AT rezvanikatayoun longtermfollowupoutcomesofpatientsthatunderwentallogeneicorautologoushematopoietictransplantshortlyafteracovid19infection
AT shpallelizabethj longtermfollowupoutcomesofpatientsthatunderwentallogeneicorautologoushematopoietictransplantshortlyafteracovid19infection